Escherichia Coli Patents (Class 435/849)
  • Patent number: 4393135
    Abstract: An L-glutamic acid producing microorganism, which is obtained by incorporation into a host strain of the genus Escherichia of a hybrid plasmid having inserted therein a DNA fragment with genetic information controlling L-glutamic acid production, said fragment being derived from a donor strain of Escherichia which is capable of producing L-glutamic acid useful for the production of high levels of L-glutamic acid.
    Type: Grant
    Filed: December 2, 1980
    Date of Patent: July 12, 1983
    Assignee: Ajinomoto Company Incorporated
    Inventors: Takayasu Tsuchida, Shigeru Nakamori
  • Patent number: 4391907
    Abstract: An L-valine-producing microorganism which is constructed by incorporation into a host strain of the genus Escherichia of a hybrid plasmid having inserted therein a DNA fragment with genetic information related to L-valine production which is derived from a donor strain of the genus Escherichia which is resistant to a valine analogue, is useful for the production of high levels of L-valine by fermentation.
    Type: Grant
    Filed: December 2, 1980
    Date of Patent: July 5, 1983
    Assignee: Ajinomoto Company Incorporated
    Inventors: Hiroshi Matsui, Takayasu Tsuchida, Shigeru Nakamori
  • Patent number: 4390629
    Abstract: Proteases derived from E. coli, and a method for preparing a proteinaceous mixture having proteolytic activity.
    Type: Grant
    Filed: March 30, 1981
    Date of Patent: June 28, 1983
    Assignee: President and Fellows of Harvard College
    Inventors: Alfred L. Goldberg, K. H. Sreedhara Swamy, Chin H. Chung
  • Patent number: 4389488
    Abstract: A process for the enzymatic preparation of L-2-amino-4-methylphosphinobutyric acid by enzymatic cleavage of the corresponding N-arylacetyl derivatives using penicillin-G-acylase.
    Type: Grant
    Filed: December 21, 1981
    Date of Patent: June 21, 1983
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Susanne Grabley, Klaus Sauber
  • Patent number: 4388405
    Abstract: A microorganism of the genus Escherichia incorporated with a hybrid plasmid, which have been inserted with a DNA fragment possessing genetic information related to L-histidine production and obtained from a mutant of the genus Escherichia, resistant to a histidine-analogue, produces L-histidine in a high yield.
    Type: Grant
    Filed: June 12, 1980
    Date of Patent: June 14, 1983
    Assignee: Ajinomoto Company Incorporated
    Inventors: Kounosuke Sano, Takayasu Tsuchida
  • Patent number: 4375514
    Abstract: PhoA mutant E. coli SB44, prepared by mutation of E. coli HB101 with an N-nitroso compound, can be used to identify and isolate recombinant plasmids into which a phoA gene has been incorporated. These plasmids can be used to transform bacteria which can be cloned and incubated to provide alkaline phosphatase in high yield. Moreover, these plasmid vectors can be modified in various ways so that the N-terminal amino acid sequence of phoA is followed in reading phase by the DNA coding for some other protein. In turn, these new plasmids can be used to transform bacteria which can be cloned and incubated to produce fusion proteins comprising the desired other protein in high yield and outside of the cell membrane in the periplasmatic space.
    Type: Grant
    Filed: August 1, 1980
    Date of Patent: March 1, 1983
    Assignee: Schering, Aktiengesellschaft
    Inventors: Gerhard Siewert, Werner Boidol, Joachim Daum
  • Patent number: 4374927
    Abstract: Microbiological methods, compositions and transformants are used for production of organic products for controlling cellular properties. Extrachromosomal elements are used which are subject to external modulation for production of a control element. The change in the amount of production of the control element allows for enhanced expression of a gene producing a poly(amino acid) product. The change in production of the control element allowing for enhanced gene expression of the product is accompanied by amplification of the product producing gene.
    Type: Grant
    Filed: February 24, 1981
    Date of Patent: February 22, 1983
    Assignee: The Board of Trustees of the Leland Stanford Jr. University
    Inventors: John J. Sninsky, Stanley N. Cohen
  • Patent number: 4374200
    Abstract: The present invention relates to novel, broad bacterial host range small plasmid deoxyribonucleic acid rings which serve as cloning vehicles for DNA fragments, particularly those separated from other plasmid rings or from chromosones, recombined with the small plasmid rings and to the processes for recombining the plasmid rings and to processes for transferring them between host bacteria. In particular, the present invention relates to the aggregate plasmid ring RP1/pRO1600, to pRO1600 and plasmid ring derivatives thereof, particularly including pRO1601; pRO1613 and pRO1614, all of which are carried for reference purposes in Pseudomonas aeruginosa ATCC 15692 (also known as strain PAO1c) and are on deposit at the Northern Regional Research Laboratories (NRRL) of the U. S. Dept. of Agriculture at Peoria, Ill. The plasmid ring RP1 (also known as R1822) is deposited in Pseudomonas aeruginosa NRRL-B-12123 (and is a known plasmid ring). The pRO1600 portion of the aggregate is a new plasmid ring.
    Type: Grant
    Filed: May 8, 1980
    Date of Patent: February 15, 1983
    Assignee: Microlife Technics, Inc.
    Inventor: Ronald H. Olsen
  • Patent number: 4371615
    Abstract: A streptomycin dependent mutant of a microorganism of the genus Escherichia which contains a plasmid containing genetic information controlling streptomycin independence maintains its properties when cultured in a medium devoid of streptomycin. The plasmid may also contain genetic information controlling the production of a chemical compound by the microorganism. Fermentation cultures of such microorganisms in media devoid of streptomycin do not lose their industrially desirable ability to synthesize useful compounds.
    Type: Grant
    Filed: May 23, 1980
    Date of Patent: February 1, 1983
    Assignee: Ajinomoto Company Incorporated
    Inventors: Kiyoshi Miwa, Haruo Momose
  • Patent number: 4371614
    Abstract: A bacterium which comprises a host of the genus Escherichia deficient in the enzyme tryptophanase carrying a plasmid with genetic information to control L-tryptophan production is useful for the fermentative production of L-tryptophan in high yields.
    Type: Grant
    Filed: August 22, 1980
    Date of Patent: February 1, 1983
    Assignee: Ajinomoto Co., Inc.
    Inventors: David M. Anderson, Klaus M. Herrmann, Ronald L. Somerville
  • Patent number: 4363877
    Abstract: Recombinant DNA transfer vectors containing codons for human somatomammotropin and for human growth hormone.
    Type: Grant
    Filed: April 19, 1978
    Date of Patent: December 14, 1982
    Assignee: The Regents of the University of California
    Inventors: Howard M. Goodman, John Shine, Peter H. Seeburg
  • Patent number: 4362817
    Abstract: A novel chemical compound, plasmid pUC1060, which was constructed from Streptomyces sp. 3022a chromosomal DNA and plasmid pBR322. Hybrid plasmid pUC1060 contains a functional tet gene promoter composed of streptomycete and E. coli DNA, and, thus, is useful as a cloning vehicle in recombinant DNA work. For example, using well known DNA methodology, a desired gene, for example, the insulin gene, can be inserted into pUC1060 and the resulting plasmid can then be transformed into a suitable host microbe which, upon culturing, produces the desired insulin.
    Type: Grant
    Filed: March 2, 1981
    Date of Patent: December 7, 1982
    Assignee: The Upjohn Company
    Inventor: Fritz Reusser
  • Patent number: 4362816
    Abstract: A novel chemical compound, plasmid pUC1031, which was constructed from Streptomyces sp. 3022a chromosomal DNA and plasmid pBR322. Hybrid plasmid pUC1031 contains a functional tet gene promoter composed of streptomycete and E. coli DNA, and, thus, is useful as a cloning vehicle in recombinant DNA work. For example, using well known DNA methodology, a desired gene, for example, the insulin gene, can be inserted into pUC1031 and the resulting plasmid can then be transformed into a suitable host microbe which, upon culturing, produces the desired insulin.
    Type: Grant
    Filed: November 13, 1980
    Date of Patent: December 7, 1982
    Assignee: The Upjohn Company
    Inventor: Fritz Reusser
  • Patent number: 4350764
    Abstract: DNA comprising the naturally occurring nucleotide sequence coding for amino acids 44-90 of .beta.-lipotropin and including the entire coding region for .beta.-endorphin with the exception of the C-terminal glutamine was modified, transferred to an expression transfer vector, and expressed as a fusion protein. The fusion protein was further modified in vitro to yield mature .beta.-endorphin. .beta.-endorphin was purified from a bacterial lysate. The structure and biological activity of the resulting product was proven by immunological assay, and by two independent assays designed to demonstrate biological activity.
    Type: Grant
    Filed: March 10, 1980
    Date of Patent: September 21, 1982
    Assignee: The Regents of the University of California
    Inventors: John D. Baxter, Ivy Fettes, John Shine
  • Patent number: 4347318
    Abstract: L-threonine is produced by incorporating into a recipient microorganism of the genus Escherichia which does not require L-threonine for growth, a plasmid, in which a deoxyribonucleic acid fragment which possesses genetic information relating to L-threonine synthesis obtained from a mutant resistant to .alpha.-amino-.beta.-hydroxy valeric acid of the genus Escherichia, has been inserted.
    Type: Grant
    Filed: April 2, 1980
    Date of Patent: August 31, 1982
    Assignee: Ajinomoto Company, Incorporated
    Inventors: Kiyoshi Miwa, Takayasu Tsuchida, Osamu Kurahashi, Shigeru Nakamori, Konosuke Sano, Haruo Momose
  • Patent number: 4346170
    Abstract: An L-lysine producing microorganism which is obtained by incorporation into a host strain of the genus Escherichia of a hybrid plasmid having inserted therein a DNA fragment with genetic information controlling L-lysine production which is derived from a donor strain which is resistant to an L-lysine analogue, is useful for the production of high levels of L-lysine by fermentation.
    Type: Grant
    Filed: July 23, 1980
    Date of Patent: August 24, 1982
    Assignee: Ajinomoto Company, Incorporated
    Inventors: Kounosuke Sano, Takayasu Tsuchida
  • Patent number: 4332900
    Abstract: Novel chemical compounds, recombinant plasmids pUC1019 and pUC-1020, which are obtained by covalent linkage of ca. 4.2 kb BclI restriction endonuclease fragment of the Streptomyces espinosus plasmid pUC6 into the BamHI endonuclease site of the E. coli plasmid pBR322. Plasmid pUC1024 is obtained by restructuring plasmid pUC1019. These plasmids are useful as cloning vehicles in recombinant DNA work. For example, using DNA methodology, a desired gene, for example, the insulin gene, can be inserted into the plasmids and the resulting plasmids can then be transformed into a suitable host microbe which, upon culturing, produces the desired insulin.
    Type: Grant
    Filed: October 1, 1980
    Date of Patent: June 1, 1982
    Assignee: The Upjohn Company
    Inventors: Jack J. Manis, Sarah K. Highlander
  • Patent number: 4332898
    Abstract: A novel chemical compound, plasmid pUC1021, which was constructed from Bacillus megaterium chromosomal DNA and plasmid pBR322. Hybrid plasmid pUC1021 contains a functional tet gene promoter, and, thus, is useful as a cloning vehicle in recombinant DNA work. For example, using well known DNA methodology, a desired gene, for example, the insulin gene, can be inserted into pUC1021 and the resulting plasmid can then be transformed into a suitable host microbe which, upon culturing, produces the desired insulin.
    Type: Grant
    Filed: June 16, 1980
    Date of Patent: June 1, 1982
    Assignee: The Upjohn Company
    Inventor: Fritz Reusser
  • Patent number: 4326030
    Abstract: Process for the production of citric acid, characterized in that E. Coli KG 93, F.sup.- is cultivated in a first step for 15-24 hours at a temperature of 20.degree.-37.degree. C. and a pH of 5.0-7.5 on a substrate consisting of whey permeate to which has been added phosphates in a content of 0.8-1.6 g/l and nitrates in a content of 0.8-1.2 g/l or a corresponding quantity of urea, that H. Wickerhamii CBS 4308 in a second step is cultivated for 20-26 hours at a temperature of 15.degree.-35.degree. C. and a pH of 4.5-6.5 on the cultivating solution from the first step, whereupon citric acid is obtained from the cultivating solution in a way known per se.
    Type: Grant
    Filed: December 5, 1979
    Date of Patent: April 20, 1982
    Assignee: Diamond Shamrock Corporation
    Inventor: Refaat M. El-Sayed
  • Patent number: 4322497
    Abstract: A method of providing maximum frequencies of transduction with Escherichia coli strains, such as E. coli K12 .chi.1776, that are transduced poorly in the exponential growth phase, which comprises transducing the culture in the stationary phase of growth. E. coli K12 .chi.1776 strains modified by transduction using this method are useful as EK2 hosts for biological containment.
    Type: Grant
    Filed: June 2, 1978
    Date of Patent: March 30, 1982
    Assignee: Eli Lilly and Company
    Inventor: Charles L. Hershberger
  • Patent number: 4321325
    Abstract: The process for producing L-threonine consists in that there is cultivated a producer of L-threonine in the capacity of which is used the Escherichia coli strain VNIIgenetika M-1 deposited in the Central museum of commercial microorganisms under the All-Union Research Institute for Genetics and Selection of Commercial Microorganisms at a registration No. IIMIIB-1856. The above strain has been selected on the basis of natural variability of the Escherichia coli strain VNIIgenetika VL 334/p YN7), obtained by virtue of the genetic engineering techniques through increasing the dose of mutant genes capable of a higher rate of L-threonine production, by introducing a multicopy hydrid plasmid carrying said genes, into a mutant recipient strain. The abovesaid producer is cultivated on a nutrient medium, containing sources of carbon, nitrogen, and some mineral salts in the presence of an antibiotic penicillin, the resultant biomass being then separated from the culture fluid, whereupon the end product is isolated.
    Type: Grant
    Filed: March 24, 1980
    Date of Patent: March 23, 1982
    Inventors: Vladimir G. Debabov, Nelli I. Zhdanova, Alexandr K. Sokolov, Vitaly A. Livshits, Jury I. Kozlov, Evgeny M. Khurges, Nikolai K. Yankovsky, Mikhail M. Gusyatiner, Albert F. Sholin, Viktor P. Antipov, Tamara M. Pozdnyakova
  • Patent number: 4286061
    Abstract: A method for the continuous culturing of microbes in a plug-flow reactor which comprises the steps of:A. supplying medium to microbes immobilized on a porous inorganic support at a rate sufficient to maintain such microbes substantially in a logarithmic growth stateandB. removing microbe-containing effluent from the immobilized microbes at a rate equal to the medium supply rate, wherein the microbes are selected from the group consisting of bacteria, yeasts, and fungus-like organisms; such reactor is operated continuously in a substantially plug-flow mode; the immobilized microbes are substantially covered by said medium; and such porous inorganic support has a controlled porosity such that at least 70% of the pores, on a pore size distribution basis, have a pore diameter,a. in the case of bacteria, at least as large as the smallest major dimension of the microbes but less than about five times the largest major dimension of the microbes;b.
    Type: Grant
    Filed: June 23, 1980
    Date of Patent: August 25, 1981
    Assignee: Corning Glass Works
    Inventors: Ralph A. Messing, Robert A. Oppermann, Lynn B. Simpson, Milton M. Takeguchi
  • Patent number: 4278593
    Abstract: A glucocorticoid sparing factor (GSF) which amplifies liver enzyme induction which is caused in glucocorticoid and a process for the production of GSF are disclosed. GSF can be isolated from the culture broth of a microorganism of the Family Enterobacteriaceae.
    Type: Grant
    Filed: January 2, 1980
    Date of Patent: July 14, 1981
    Inventor: Nobuhiko Katsunuma
  • Patent number: 4264731
    Abstract: A selected portion of DNA molecules having reactant ends which are capable of being joined in a ligase catalyzed reaction are pretreated so a to remove the 5'-terminal phosphate groups. Such a treatment reduces the frequency of joining an undersired combination and enhances the frequency of joining the desired combination.
    Type: Grant
    Filed: April 21, 1978
    Date of Patent: April 28, 1981
    Assignee: The Regents of the University of California
    Inventor: John Shine
  • Patent number: 4237224
    Abstract: Method and compositions are provided for replication and expression of exogenous genes in microorganisms. Plasmids or virus DNA are cleaved to provide linear DNA having ligatable termini to which is inserted a gene having complementary termini, to provide a biologically functional replicon with a desired phenotypical property. The replicon is inserted into a microorganism cell by transformation. Isolation of the transformants provides cells for replication and expression of the DNA molecules present in the modified plasmid. The method provides a convenient and efficient way to introduce genetic capability into microorganisms for the production of nucleic acids and proteins, such as medically or commercially useful enzymes, which may have direct usefulness, or may find expression in the production of drugs, such as hormones, antibiotics, or the like, fixation of nitrogen, fermentation, utilization of specific feedstocks, or the like.
    Type: Grant
    Filed: January 4, 1979
    Date of Patent: December 2, 1980
    Assignee: Board of Trustees of the Leland Stanford Jr. University
    Inventors: Stanley N. Cohen, Herbert W. Boyer
  • Patent number: 4190495
    Abstract: Microorganisms have been developed which may be characterized as possessing substantially all of the following qualities or capabilities:(a) capable of having foreign genetic information introduced thereinto and recovered therefrom along with its expression with production of useful gene products;(b) the microorganism being dependent for growth and survival upon defined conditions;(c) the microorganism being incapable of establishment or growth or colonization and/or survival under conditions or in ecological niches that are considered to be natural and/or undesirable for said microorganism;(d) the microorganism being capable of causing genetic information incorporated therein to undergo degradation under conditions or ecological niches that are considered to be natural and/or undesirable for said microorganism;(e) the microorganism being capable of permitting cloning vectors incorporated therein to be dependent for their replication, maintenance and/or function on said microorganism;(f) the microorganism bei
    Type: Grant
    Filed: September 27, 1976
    Date of Patent: February 26, 1980
    Assignee: Research Corporation
    Inventor: Roy Curtiss, III
  • Patent number: 4166767
    Abstract: An insolubilized antibody suitable for an enzyme immuno assay or radio immuno assay, which has characteristic infrared absorptions at around 1,040 cm.sup.-1, 1,540 cm.sup.-1 and 1,640 cm.sup.-1 and is prepared by chemically binding an antibody to cell wall debris of bacteria or yeasts whose shape is globular or rod-like. There is further disclosed an enzyme immuno assay or radio immuno assay using the insolubilized antibody and a kit containing the insolubilized antibody.
    Type: Grant
    Filed: March 16, 1977
    Date of Patent: September 4, 1979
    Assignee: Dainippon Pharmaceutical Co., Ltd.
    Inventors: Shigeru Kurooka, Noriyuki Sunahara